Takashi Shiraki
Kyoto University
24 Papers
280 Citations
Takashi Shiraki is an academic researcher from Kyoto University. The author has contributed to research in topics: DNA & Dynemicin A. The author has an hindex of 12, co-authored 24 publications. Previous affiliations of Takashi Shiraki include Takeda Pharmaceutical Company & Himeji Dokkyo University.
Chat about Author
Papers
Photoinduced biochemical activity of fullerene carboxylic acid
TL;DR: It is found that even low-energy visible light is surfficient to induce biological activity in fullerene derivatives, suggesting that fullerenes may serve as useful photosensitive biochemical probes.
613
Biological Activity of Water-Soluble Fullerenes. Structural Dependence of DNA Cleavage, Cytotoxicity, and Enzyme Inhibitory Activities Including HIV-Protease Inhibition
TL;DR: Two different classes of water-soluble fullerene derivatives, detergent-type and sphere-type, were synthesized and found to be photo-inactive with respect to DNA cleaving activity and cytotoxicity and potent HIV protease inhibitor.
186
Visible light induced DNA cleavage by the hybrid antitumor antibiotic dynemicin A.
Takashi Shiraki,Yukio Sugiura +1 more
TL;DR: The observed nucleotide cutting specificity is remarkably similar to that of NADPH- (or thiol) induced DNA breakage with dynemicin A, suggesting the presence of the same DNA-cleaving intermediate.
88
Pioglitazone Improves Insulin Signaling Defects in Skeletal Muscle from Wistar Fatty (fa/fa) Rats
TL;DR: Results indicate that pioglitazone can correct the insulin signaling defects of Wistar fatty rats, thereby ameliorating insulin resistance.
55